|
||||||
Executive Summary Emphysema-Pipeline Review, H1 2015 Summary Global Markets Direct's, 'Emphysema-Pipeline Review, H1 2015', provides an overview of the Emphysema's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Emphysema, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Emphysema and special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope The report provides a snapshot of the global therapeutic landscape of Emphysema The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities The report reviews key players involved in the therapeutics development for Emphysema and enlists all their major and minor projects The report summarizes all the dormant and discontinued pipeline projects A review of the Emphysema products under development by companies and universities/research institutes based on information derived from company and industry-specific sources Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages A detailed assessment of monotherapy and combination therapy pipeline projects Coverage of the Emphysema pipeline on the basis of target, MoA, route of administration and molecule type Latest news and deals relating related to pipeline products Reasons To Buy Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Develop strategic initiatives by understanding the focus areas of leading companies Identify and understand important and diverse types of therapeutics under development for Emphysema Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline Devise corrective measures for pipeline projects by understanding Emphysema pipeline depth and focus of Indication therapeutics Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Read More Contact Us:
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Introduction 5 Global Markets Direct Report Coverage 5 Emphysema Overview 6 Therapeutics Development 7 Pipeline Products for Emphysema-Overview 7 Pipeline Products for Emphysema-Comparative Analysis 8 Emphysema-Therapeutics under Development by Companies 9 Emphysema-Pipeline Products Glance 10 Late Stage Products 10 Early Stage Products 11 Emphysema-Products under Development by Companies 12 Emphysema-Companies Involved in Therapeutics Development 13 Angion Biomedica Corp. 13 Boehringer Ingelheim GmbH 14 Intrexon Corporation 15 Protalix BioTherapeutics, Inc. 16 rEVO Biologics 17 Emphysema-Therapeutics Assessment 18 Assessment by Monotherapy Products 18 Assessment by Combination Products 19 Assessment by Target 20 Assessment by Mechanism of Action 22 Assessment by Route of Administration 24 Assessment by Molecule Type 26 Drug Profiles 28 (olodaterol + tiotropium bromide)-Drug Profile 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 Alpha-1 Antitrypsin With rHuPH20-Drug Profile 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 BB-3-Drug Profile 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 EDO-66-Drug Profile 34 Product Description 34 Mechanism of Action 34 R&D Progress 34 Monoclonal Antibody to Inhibit EMAP II for Emphysema-Drug Profile 35 Product Description 35 Mechanism of Action 35 R&D Progress 35 PRX-107-Drug Profile 36 Product Description 36 Mechanism of Action 36 R&D Progress 36 Recombinant Human Alpha-1 Antitrypsin-Drug Profile 37 Product Description 37 Mechanism of Action 37 R&D Progress 37 TRN-101-Drug Profile 38 Product Description 38 Mechanism of Action 38 R&D Progress 38 Emphysema-Recent Pipeline Updates 39 Emphysema-Dormant Projects 42 Emphysema-Product Development Milestones 43 Featured News & Press Releases 43 Jun 20, 2013: Protalix BioTherapeutics Reveals Information For Emphysema Drug, PRX-107 43 Appendix 44 Methodology 44 Coverage 44 Secondary Research 44 Primary Research 44 Expert Panel Validation 44 Contact Us 44 Disclaimer 45 List of Tables Number of Products under Development for Emphysema, H1 2015 7 Number of Products under Development for Emphysema-Comparative Analysis, H1 2015 8 Number of Products under Development by Companies, H1 2015 9 Comparative Analysis by Late Stage Development, H1 2015 10 Comparative Analysis by Early Stage Development, H1 2015 11 Products under Development by Companies, H1 2015 12 Emphysema-Pipeline by Angion Biomedica Corp., H1 2015 13 Emphysema-Pipeline by Boehringer Ingelheim GmbH, H1 2015 14 Emphysema-Pipeline by Intrexon Corporation, H1 2015 15 Emphysema-Pipeline by Protalix BioTherapeutics, Inc., H1 2015 16 Emphysema-Pipeline by rEVO Biologics, H1 2015 17 Assessment by Monotherapy Products, H1 2015 18 Assessment by Combination Products, H1 2015 19 Number of Products by Stage and Target, H1 2015 21 Number of Products by Stage and Mechanism of Action, H1 2015 23 Number of Products by Stage and Route of Administration, H1 2015 25 Number of Products by Stage and Molecule Type, H1 2015 27 Emphysema Therapeutics-Recent Pipeline Updates, H1 2015 39 Emphysema-Dormant Projects, H1 2015 42 List of Figures Number of Products under Development for Emphysema, H1 2015 7 Number of Products under Development for Emphysema-Comparative Analysis, H1 2015 8 Number of Products under Development by Companies, H1 2015 9 Comparative Analysis by Early Stage Products, H1 2015 11 Assessment by Monotherapy Products, H1 2015 18 Number of Products by Top 10 Targets, H1 2015 20 Number of Products by Stage and Top 10 Targets, H1 2015 21 Number of Products by Top 10 Mechanism of Actions, H1 2015 22 Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 23 Number of Products by Top 10 Routes of Administration, H1 2015 24 Number of Products by Stage and Top 10 Routes of Administration, H1 2015 25 Number of Products by Top 10 Molecule Types, H1 2015 26 Number of Products by Stage and Top 10 Molecule Types, H1 2015 27 Single User License: Site License: Corporate User License: Angion Biomedica Corp. Boehringer Ingelheim GmbH Intrexon Corporation Protalix BioTherapeutics, Inc. rEVO Biologics Emphysema Therapeutic Products under Development, Key Players in Emphysema Therapeutics, Emphysema Pipeline Overview, Emphysema Pipeline, Emphysema Pipeline Assessment |
select a license |
||
NEWSLETTER BY CATEGORY
|
||
Testimonials
|
||
The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center" |